Institutions Pull $1B From Bitcoin ETFs; XRP, Solana Gain
Spot Bitcoin ETFs saw $1 billion in outflows May 11–15 as ARKB and IBIT led withdrawals; XRP ETFs added $60.5M and Solana ETFs $58.12M.
During the week of May 11–15, institutional investors withdrew $1 billion from spot Bitcoin exchange-traded funds, ending a six-week inflow streak. Ark & 21Shares’ ARKB recorded $324.2 million in net outflows and BlackRock’s IBIT lost $317.1 million.
Other Bitcoin products with outflows included Fidelity’s FBTC (-$259 million), Grayscale’s GBTC (-$92.8 million), Bitwise’s BITB (-$46.8 million) and Franklin’s EZBC (-$21 million). A small number of funds had inflows: Morgan Stanley’s MSBT added $39.1 million, Vaneck’s HODL gained $12.1 million, another Grayscale Bitcoin product added $12.6 million and Invesco’s BTCO posted $1.6 million.
Trading volume remained elevated throughout the period.
Spot ether ETFs recorded $255.11 million in net outflows for the week. BlackRock’s ETHA and Fidelity’s FETH were the primary drivers of those declines. BlackRock’s ETHB attracted intermittent inflows that partially offset losses within the ether ETF group.
Outside Bitcoin and ether, spot XRP ETFs posted $60.5 million in net inflows. Products from Franklin, Bitwise, Canary and Grayscale drew investor capital. Market participants cited the proposed CLARITY Act and potential uses for institutional settlement as reasons for interest in XRP funds.
Solana ETFs added $58.12 million in net inflows, led by Bitwise’s BSOL and Fidelity’s FSOL. Market participants pointed to Solana’s developing ecosystem and scalability as factors behind investor demand.
Trading activity across crypto ETFs stayed high as capital moved between funds during the week.
The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.
Articles by this author
